Elsevier

Metabolism

Volume 45, Issue 2, February 1996, Pages 229-234
Metabolism

Reduced Na+K+ adenosine triphosphatase activity and motor nerve conduction velocity in l-fucose-fed rats is reversible after dietary normalization

https://doi.org/10.1016/S0026-0495(96)90059-1Get rights and content

Abstract

Development of early defects in diabetic neuropathy has been linked to metabolic abnormalities and is considered reversible. To further address some of the questions concerning the contribution by metabolic derangements to the development of neural defects and reversibility, we have developed an animal model, by feeding rats a diet containing 20% l-fucose, that develops neural defects similar to those that occur in streptozotocin-induced diabetic rats. After 6 weeks on a 20% l-fucose diet, myo-inositol content and Na+K+ adenosine triphosphatase (ATPase) activity of the sciatic nerve were significantly reduced, as was the motor nerve conduction velocity (MNCV). l-Fucose is a monosaccharide that occurs in low concentrations in normal serum but is increased in diabetic patients. In cultured cells, l-fucose, at concentrations that occur in diabetic circulation, is a competitive inhibitor of myo-inositol uptake. The purpose of the present study was to compare the sequential pattern of the reversibility of the slowing of MNCV with ouabain-inhibited sciatic nerve Na+K+ ATPase activity and myo-inositol content in rats fed a diet containing 20% l-fucose for a period of 6 weeks followed by a normal diet lasting up to 2 weeks. Unbound l-fucose levels in the serum returned to normal in less than 24 hours of the rats being placed on the normal diet. Normalization of slowed MNCV after removing l-fucose-fed rats from the l-fucose diet followed a pattern of recovery similar to the recovery of sciatic nerve ouabain-inhibited Na+K+ ATPase activity, with complete recovery occurring within 7 days of the rats being placed on the normal diet. In contrast, myo-inositol content of the sciatic nerve remained decreased following 3 days on the normal diet, and required 14 days for complete normalization. Results from these studies suggest that a causal relationship may exist for reduced Na+K+ ATPase activity and MNCV in l-fucose-fed rats, and that a measurable decrease in myo-inositol content may not be necessary for the development of these defects in the sciatic nerve.

References (38)

  • RS Clements et al.

    Abnormal sciatic nerve myo-inositol metabolism in the streptozotocin-diabetic rat

    Diabetes

    (1980)
  • KRW Gillon et al.

    Transport of myo-inositol into endoneurial preparations of sciatic nerve from normal and streptozotocin-diabetic rats

    Biochem J

    (1983)
  • DA Greene et al.

    Nerve Na+-K+-ATPase, conduction and myo-inositol in the insulin deficient BB-rat

    Am J Physiol

    (1984)
  • KRW Gillon et al.

    myo-Inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: The effect of aldose reductase inhibition

    Diabetologia

    (1983)
  • DA Greene et al.

    Action of sorbinil in diabetic peripheral nerve

    Diabetes

    (1984)
  • DR Tomlinson et al.

    Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor sorbinil

    Diabetes

    (1984)
  • DA Greene et al.

    Decreased myo-inositol content and Na+-K+-ATPase activity in superior cervical ganglion of STZ-diabetic rat and prevention by aldose reductase inhibition

    Diabetes

    (1986)
  • DA Greene et al.

    Perspectives in diabetes: Are disturbances of sorbitol, phosphoinositide, and Na+-K+-ATPase regulation involved in pathogenesis of diabetic neuropathy?

    Diabetes

    (1988)
  • J Kim et al.

    Normalization of Na+-K+-ATPase activity in isolated membrane fraction from sciatic nerves of streptozotocin-induced diabetic rats by dietary myo-inositol supplementation in vivo or protein kinase C agonists in vitro

    Diabetes

    (1991)
  • Cited by (9)

    • Safety evaluation of the human-identical milk monosaccharide, l-fucose

      2015, Regulatory Toxicology and Pharmacology
      Citation Excerpt :

      This hypothesis was borne out by the finding that supplementation of the diet with 1% myo-inositol prevented these changes. The results of the studies by Yorek et al. (1993, 1996) and Sima et al. (1997), however, are of no relevance to the safety assessment of HiMM l-fucose due to the use of dietary concentrations well in excess of those recommended as the maximum to be used in subchronic toxicity studies (i.e., 5% in the diet) so as to avoid effects associated with nutritional and/or caloric imbalances (WHO, 1987). At lower levels of l-fucose exposure, as shown in the current study at 1.0% in the diet, there is no effect of l-fucose administration on indices of neural function, including the results of the FOB testing, clinical/cage-side examinations, and histopathological examination of nerve tissue.

    View all citing articles on Scopus

    Supported by National Institutes of Health Grants No. DK25295 and DK45453 and a grant from the Juvenile Diabetes Foundation (393776).

    View full text